312 related articles for article (PubMed ID: 19781441)
21. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
[TBL] [Abstract][Full Text] [Related]
22. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
[TBL] [Abstract][Full Text] [Related]
23. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
[TBL] [Abstract][Full Text] [Related]
24. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
[TBL] [Abstract][Full Text] [Related]
25. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
[TBL] [Abstract][Full Text] [Related]
28. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
Yang Y; Niu ZB; Hou Y; Wang CL
J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
[TBL] [Abstract][Full Text] [Related]
29. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.
Sheu JJ; Hua CH; Wan L; Lin YJ; Lai MT; Tseng HC; Jinawath N; Tsai MH; Chang NW; Lin CF; Lin CC; Hsieh LJ; Wang TL; Shih IeM; Tsai FJ
Cancer Res; 2009 Mar; 69(6):2568-76. PubMed ID: 19276369
[TBL] [Abstract][Full Text] [Related]
30. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Bizari L; Borim AA; Leite KR; Gonçalves Fde T; Cury PM; Tajara EH; Silva AE
Cancer Genet Cytogenet; 2006 Feb; 165(1):41-50. PubMed ID: 16490596
[TBL] [Abstract][Full Text] [Related]
31. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
Okada Y; Hurwitz EE; Esposito JM; Brower MA; Nutt CL; Louis DN
Cancer Res; 2003 Jan; 63(2):413-6. PubMed ID: 12543796
[TBL] [Abstract][Full Text] [Related]
32. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
33. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas.
Tabori U; Rienstein S; Dromi Y; Leider-Trejo L; Constantini S; Burstein Y; Dvir R; Amariglio N; Toren A; Rechavi G; Izraeli S; Aviram A
J Neurosurg; 2005 Oct; 103(4 Suppl):357-61. PubMed ID: 16270688
[TBL] [Abstract][Full Text] [Related]
35. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
37. Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cells.
Singer CF; Hudelist G; Fuchs EM; Köstler W; Fink-Retter A; Gschwantler-Kaulich D; Gnant M; Lamm W; Rudas M; Czerwenka K; Kubista E
Endocr Relat Cancer; 2009 Mar; 16(1):73-83. PubMed ID: 18948375
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Cox-2 expression in Wilms' tumor.
Giordano G; Campanini N; Donofrio V; Bertolini P; Falleti J; Grassani C; Pettinato G
Pathol Res Pract; 2008; 204(12):875-82. PubMed ID: 18752906
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L
Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189
[TBL] [Abstract][Full Text] [Related]
40. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.
Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; Natrajan R; Kelsey A; Rogers S; Campbell C; Pritchard-Jones K; Khan J
Genes Chromosomes Cancer; 2004 Sep; 41(1):65-79. PubMed ID: 15236318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
